# Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis

> **NCT06237153** · PHASE2 · RECRUITING · sponsor: **Marie Badalamente** · enrollment: 30 (estimated)

## Conditions studied

- Carpometacarpal (CMC) Osteoarthritis

## Interventions

- **DRUG:** Triamcinolone Acetonide extended release suspension

## Key facts

- **NCT ID:** NCT06237153
- **Lead sponsor:** Marie Badalamente
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-21
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237153, "Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06237153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*